Extranodal NK-T-cell lymphoma staging: Difference between revisions
No edit summary |
|||
(6 intermediate revisions by 2 users not shown) | |||
Line 6: | Line 6: | ||
==Staging== | ==Staging== | ||
* Extranodal NK/T cell lymphoma survival rate is not well predicted by [[Ann Arbor staging system]]. A new system was introduced by a Korean study based on [[B symptoms]], [[Ann Arbor Staging|Ann Arbor system]], [[LDH]] level, and regional [[lymphadenopathy]] combined.Four risk groups identified as below: | * Extranodal NK/T cell lymphoma survival rate is not well predicted by [[Ann Arbor staging system]]<ref name="pmid12876666">{{cite journal| author=Jaffe ES, Krenacs L, Raffeld M| title=Classification of cytotoxic T-cell and natural killer cell lymphomas. | journal=Semin Hematol | year= 2003 | volume= 40 | issue= 3 | pages= 175-84 | pmid=12876666 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12876666 }} </ref>|<ref name="pmid16888893">{{cite journal| author=Feller AC| title=[Classification and differential diagnosis of NK/T-cell lymphomas]. | journal=Verh Dtsch Ges Pathol | year= 2003 | volume= 87 | issue= | pages= 43-52 | pmid=16888893 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16888893 }}</ref>. | ||
*A new system was introduced by a Korean study based on [[B symptoms]], [[Ann Arbor Staging|Ann Arbor system]], [[LDH]] level, and regional [[lymphadenopathy]] combined.Four risk groups identified as below: | |||
# group 1: No adverse factor | # group 1: No adverse factor | ||
Line 36: | Line 37: | ||
|} | |} | ||
* Another parallel mechanism for extranodal NK/T cell lymphoma is based on tumor biologic and micro-environmental factors. High Ki-67 nuclear antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk. | * Another parallel mechanism for extranodal NK/T cell lymphoma is based on [[tumor]] [[Biology|biologic]] and micro-environmental factors. High Ki-67 [[nuclear]] antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk. | ||
==References== | ==References== |
Latest revision as of 14:00, 2 October 2019
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma staging On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma staging |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Extranodal NK/T cell lymphoma survival rate is not well predicted by Ann Arbor staging system. A new system was introduced based on B symptoms, Ann Arbor system, LDH level, and regional lymphadenopathy combined. Another parallel mechanism for extranodal NK/T cell lymphoma is based on tumor biologic and micro-environmental factors. High Ki-67 nuclear antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk.
Staging
- Extranodal NK/T cell lymphoma survival rate is not well predicted by Ann Arbor staging system[1]|[2].
- A new system was introduced by a Korean study based on B symptoms, Ann Arbor system, LDH level, and regional lymphadenopathy combined.Four risk groups identified as below:
- group 1: No adverse factor
- group 2: One factor
- group 3: Two factors
- group 4: Three or more factors
Group | Altered factors count | 5 year prognosis |
---|---|---|
1 | N.O. | 81000 out of 100000 |
2 | 1 | 64000 out of 100000 |
3 | 2 | 34000 out of 100000 |
4 | 3/More | 7000 out of 100000 |
- Another parallel mechanism for extranodal NK/T cell lymphoma is based on tumor biologic and micro-environmental factors. High Ki-67 nuclear antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk.
References
- ↑ Jaffe ES, Krenacs L, Raffeld M (2003). "Classification of cytotoxic T-cell and natural killer cell lymphomas". Semin Hematol. 40 (3): 175–84. PMID 12876666.
- ↑ Feller AC (2003). "[Classification and differential diagnosis of NK/T-cell lymphomas]". Verh Dtsch Ges Pathol. 87: 43–52. PMID 16888893.